NPCE Earnings & Financial Statements
NeuroPace, Inc.
$12.67
+$0.28(+2.26%)
35
Overall
40
Value
10
Tech
55
Quality
Market Cap
$434.89M
Volume
72.64K
52W Range
$9.22 - $19.60
Target Price
$19.55
NPCE earnings and financial statements: NeuroPace, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
NPCE Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $99.99M | $79.91M | $65.42M | $45.52M | $45.18M |
| Cost of revenue | $22.77M | $20.82M | $17.30M | $13.03M | $11.75M |
| Operating income | -$16.34M | -$21.67M | -$27.17M | -$40.79M | -$23.74M |
| EBITDA | -$11.82M | -$16.35M | -$31.04M | -$36.57M | -$28.10M |
| Net income | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M |
| EPS (diluted) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $105.56M | $94.65M | $107.65M | $114.11M | $133.56M |
| Total liabilities | $86.53M | $86.63M | $87.00M | $79.33M | $60.06M |
| Shareholders’ equity | $19.03M | $8.01M | $20.65M | $34.78M | $73.50M |
| Cash and equivalents | $21.69M | $13.43M | $18.06M | $6.61M | $19.19M |
| Long-term debt | $68.72M | $71.48M | $70.77M | $68.35M | $49.85M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$11.01M | -$17.95M | -$19.70M | -$36.87M | -$24.58M |
| Capital expenditure | -$332.0K | -$306.0K | -$173.0K | -$603.0K | -$384.0K |
| Free cash flow | -$11.34M | -$18.25M | -$19.87M | -$37.47M | -$24.96M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NPCE | $12.67 | +2.3% | 72.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |